---
figid: PMC8402591__vaccines-09-00885-g001
figtitle: 'Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation
  Patients: A Narrative Review'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC8402591
filename: vaccines-09-00885-g001.jpg
figlink: /pmc/articles/PMC8402591/figure/vaccines-09-00885-f001/
number: F1
caption: 'The mechanism of the impaired generation of neutralizing antibody after
  SARS-CoV-2 vaccine injection in CKD and KT patients. In CKD patients, the vitamin
  D deficiency, uremic toxin accumulation and erythropoietin deficiency could influence
  the antigen presenting ability of the antigen presenting cell (APC). In kidney transplantation
  (KT) patients, the corticosteroid, calcineurin inhibitor (tacrolimus or cyclosporin),
  mycopheloic acid (MPA) and mechanistic target of rapamycin (mTOR) inhibitor decrease
  the activity of T cells and the production of neutralizing antibody by B Cells in
  different aspects.IL2: interleukin 2; JAK-PI3K: Janus-activated kinase/phosphoinositide
  3-kinase pathway; MHC: major histocompatibility complex.'
papertitle: 'The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney
  Transplantation Patients: A Narrative Review.'
reftext: Yi-Chou Hou, et al. Vaccines (Basel). 2021 Aug;9(8):885.
year: '2021'
doi: 10.3390/vaccines9080885
journal_title: Vaccines
journal_nlm_ta: Vaccines (Basel)
publisher_name: MDPI
keywords: chronic kidney disease | COVID-19 | dialysis | kidney transplantation |
  SARS-CoV-2 | vaccine
automl_pathway: 0.9497941
figid_alias: PMC8402591__F1
figtype: Figure
redirect_from: /figures/PMC8402591__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8402591__vaccines-09-00885-g001.html
  '@type': Dataset
  description: 'The mechanism of the impaired generation of neutralizing antibody
    after SARS-CoV-2 vaccine injection in CKD and KT patients. In CKD patients, the
    vitamin D deficiency, uremic toxin accumulation and erythropoietin deficiency
    could influence the antigen presenting ability of the antigen presenting cell
    (APC). In kidney transplantation (KT) patients, the corticosteroid, calcineurin
    inhibitor (tacrolimus or cyclosporin), mycopheloic acid (MPA) and mechanistic
    target of rapamycin (mTOR) inhibitor decrease the activity of T cells and the
    production of neutralizing antibody by B Cells in different aspects.IL2: interleukin
    2; JAK-PI3K: Janus-activated kinase/phosphoinositide 3-kinase pathway; MHC: major
    histocompatibility complex.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Mhc
  - zip
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - Mtor
  - Tor
  - CycE
  - cyc
  - NFAT
  - Dif
  - dl
  - Rel
  - lncRNA:iab8
  - de
  - EPO
  - TIMP1
  - EPX
  - HLA-C
  - CD80
  - CD86
  - APC
  - PROC
  - IL2
  - MTOR
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
---
